Infectious Disease

NCI-CCC Myeloma Tumor Board Question

Questions discussed in this category

Would you offer live vaccines (e.g., MMRV/measles) to patients on bispecific antibodies for multiple myeloma?

This comes up from time to time, but especially in 2025 with the multistate outbreaks and the rising adoption of bispecific antibodies (e.g., teclista...

2 Answers available

What infectious prophylaxis do you use for patients with newly diagnosed multiple myeloma?

How do you decide how long to continue?

1 Answer available

Papers discussed in this category

Lancet Oncol, 2019 Oct 23

Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.

PloS one, 2025 Feb 07

Measles neutralising antibody levels in patients receiving intravenous immunoglobulin treatment - a sub-analysis of a randomized, cross-over bioequivalence trial.

Vaccine, 2021 Aug 25

Live attenuated vaccine efficacy six months after intravenous immunoglobulin therapy for Kawasaki disease.

Infectious Disease

NCI-CCC Myeloma Tumor Board Question

Questions discussed in this category

Papers discussed in this category

Related Topics in Infectious Disease